Precision Drug Discovery
Increase success rates and lower drug discovery costs.
Revolutionise drug discovery with Tartan Cell Technologies’ innovative screening platform, detecting variation in drug response early and increasing success rates while lowering costs.
Diversity during pre-trial drug discovery
Different people show varied responses when treated with the same drug. The current drug development R&D pipeline does not reflect this diversity.
We aim to change that.
Genetic-informed screening platform
Tartan Cell Technologies’ platform uses human induced pluripotent stem cells (iPSC Lines) to observe drug response in relevant cell types, which can differentiate into any terminal cell type.
We discovered a way to measure variation in drug response from iPSC lines derived from different donors and use biomarkers to understand the genetic and biochemical basis for the observed variability, leading to the development of better drug candidates earlier in the drug discovery process.